[1]
Li, Y. 2024. Beta-Amyloid Monoclonal Antibodies for Alzheimer’s Disease: Development and Challenges. Transactions on Materials, Biotechnology and Life Sciences. 7, (Dec. 2024), 846–853. DOI:https://doi.org/10.62051/tqpmmr64.